Last Updated: May 10, 2026

List of Excipients in API TREPROSTINIL


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing TREPROSTINIL

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
United Therapeutics Corporation REMODULIN treprostinil 66302-101 HYDROCHLORIC ACID
United Therapeutics Corporation REMODULIN treprostinil 66302-101 METACRESOL
United Therapeutics Corporation REMODULIN treprostinil 66302-101 SODIUM CHLORIDE
United Therapeutics Corporation REMODULIN treprostinil 66302-101 SODIUM HYDROXIDE
United Therapeutics Corporation REMODULIN treprostinil 66302-101 TRISODIUM CITRATE DIHYDRATE
United Therapeutics Corporation REMODULIN treprostinil 66302-101 WATER
United Therapeutics Corporation REMODULIN treprostinil 66302-111 HYDROCHLORIC ACID
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing TREPROSTINIL

Company Ingredient NDC Excipient
Teva Parenteral Medicines Inc treprostinil 0703-0666 HYDROCHLORIC ACID
Teva Parenteral Medicines Inc treprostinil 0703-0666 METACRESOL
Teva Parenteral Medicines Inc treprostinil 0703-0666 SODIUM CHLORIDE
Teva Parenteral Medicines Inc treprostinil 0703-0666 SODIUM CITRATE
Teva Parenteral Medicines Inc treprostinil 0703-0666 SODIUM HYDROXIDE
Teva Parenteral Medicines Inc treprostinil 0703-0666 WATER
Sandoz Inc treprostinil 0781-3420 HYDROCHLORIC ACID
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for TREPROSTINIL

Excipient focus: ALCOHOL

Excipient focus: BUTYL ALCOHOL

Excipient focus: CELLULOSE ACETATE

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: FUMARYL DIKETOPIPERAZINE

TREPROSTINIL drug variants not containing FUMARYL DIKETOPIPERAZINE

Company Ingredient NDC
Teva Parenteral Medicines Inc treprostinil 0703-0666
Sandoz Inc treprostinil 0781-3420
Endo USA Inc treprostinil 42023-209
DrReddy's Laboratories Inc treprostinil 43598-649
Alembic Pharmaceuticals Inc treprostinil 62332-514
United Therapeutics Corporation treprostinil 66302-101
United Therapeutics Corporation treprostinil 66302-111
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: HYDROCHLORIC ACID

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LEUCINE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: METACRESOL

Excipient focus: POLYETHYLENE GLYCOL 3350

TREPROSTINIL drug variants not containing POLYETHYLENE GLYCOL 3350

Company Ingredient NDC
Teva Parenteral Medicines Inc treprostinil 0703-0666
Sandoz Inc treprostinil 0781-3420
Endo USA Inc treprostinil 42023-209
DrReddy's Laboratories Inc treprostinil 43598-649
Alembic Pharmaceuticals Inc treprostinil 62332-514
United Therapeutics Corporation treprostinil 66302-101
United Therapeutics Corporation treprostinil 66302-111
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

TREPROSTINIL drug variants not containing SODIUM CITRATE

Company Ingredient NDC
Endo USA Inc treprostinil 42023-209
DrReddy's Laboratories Inc treprostinil 43598-649
United Therapeutics Corporation treprostinil 66302-101
United Therapeutics Corporation treprostinil 66302-111
United Therapeutics Corporation treprostinil 66302-206
United Therapeutics Corporation treprostinil 66302-300
United Therapeutics Corporation treprostinil 66302-616
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

TREPROSTINIL drug variants not containing SODIUM LAURYL SULFATE

Company Ingredient NDC
Teva Parenteral Medicines Inc treprostinil 0703-0666
Sandoz Inc treprostinil 0781-3420
Endo USA Inc treprostinil 42023-209
DrReddy's Laboratories Inc treprostinil 43598-649
Alembic Pharmaceuticals Inc treprostinil 62332-514
United Therapeutics Corporation treprostinil 66302-101
United Therapeutics Corporation treprostinil 66302-111
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TREHALOSE DIHYDRATE

Excipient focus: TRIETHYL CITRATE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

TREPROSTINIL drug variants containing WATER

Company Ingredient NDC
Teva Parenteral Medicines Inc treprostinil 0703-0666
Endo USA Inc treprostinil 42023-209
DrReddy's Laboratories Inc treprostinil 43598-649
Alembic Pharmaceuticals Inc treprostinil 62332-514
United Therapeutics Corporation treprostinil 66302-101
United Therapeutics Corporation treprostinil 66302-111
United Therapeutics Corporation treprostinil 66302-206
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: XYLITOL

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links